PI3K and ERK/MAPK signaling pathways mediate regulation of Sema3E/Plexin-D1-induced EMT. by Chun-Hsien Tseng (222830)

“…<p><b>A</b>, Cell transwell invasion assay of P0-3E-₁ cells reveals a significant decrease in migratory cell activity following pharmacological inhibition of PI3 kinase (LY294002, or wortmannin) and ERK/MAPK (PD98059) but not p38 mitogen activated protein kinase (SB203580), PKC (GF109203X), or Jun-N-terminal kinase (SP600125). …”

Frequency-dependent effects of FSK on AHP and Kv2.1 current. by Luis I. Angel-Chavez (736879)

DataSheet_1_Entomopathogenic fungi based microbial insecticides and their physiological and biochemical effects on Spodoptera frugiperda (J.E. Smith).docx by Perumal Vivekanandhan (4863484)

Accumulation of Atto565 and Atto565-biotin in <i>E</i>. <i>coli</i> expressing streptavidin either in the periplasm or cytoplasm. by Ankit Pandeya (9295544)

The effects of ATG13 or ULK1 mutant, ULK1-ATG13 DKO, CDK1 inhibition on autophagy. by Zhiyuan Li (205620)

HIV-1 Env generalized neutralization sensitivity impacts differentially on the potency of broadly neutralizing antibodies (bnAbs). by Caio Foulkes (20592250)

Impaired differentiation of alveolar epithelial type I cells in E18.5 <i>Snx5^-/-</i> lungs. by Sun-Kyoung Im (36750)

“…The nuclei were stained with Hoechst. Scale bars: 50 µm. (B) Decreased protein expression of T1α in E18.5 (n  =  4). …”

Table_1_Central Multifocal Choroiditis: Platelet Granularity as a Potential Marker for Treatment With Steroid-Sparing Immunomodulatory Therapy.docx by Evianne L. de Groot (11937257)

Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis by Lu CHANG (13639620)

“…H19 and miR-675-5p expressions decreased after ginsenoside Rd treatment, while CDH1 and E-cadherin expressions increased. …”

Protein identification list. by Yang Zhang (30734)

“…After MEL treatment, the expression of collagen III and α-SMA decreased, the expression of E-cadherin increased, and the expression of vimentin and N-cadherin also decreased. …”

G3BP1 and TIA-1 double-KD cells, which had decreased MuV-induced SGs, partly increased MuV-induced IFN-λ1 production, but did not affect MuV replication. by Shin Hashimoto (3079659)

The Base-Editing Enzyme APOBEC3A Catalyzes Cytosine Deamination in RNA with Low Proficiency and High Selectivity by Aleksia Barka (12218135)

“…Altogether, our work reveals a relationship between the overall decreased reactivity of A3A and increased substrate selectivity, and our results hold implications both for characterizing off-target mutagenesis and for engineering optimized DNA deaminases for base-editing technologies.…”

Table_1_Family psychoeducation to improve outcome in caregivers and patients with schizophrenia: a randomized clinical trial.docx by Arnaud Tessier (1734355)

“…</p>Results<p>On the 25 patients included, the mean age was 33.3 years (SD = 9.7) with a mean duration of disease of 7.48 years (SD = 7.1). …”

Table_6_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

“…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”

Table_7_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

“…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”

Table_1_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

“…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”

Table_5_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

“…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”

Table_3_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

“…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”

Table_2_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.DOCX by Zhenyan Song (17434881)

“…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”

Table_4_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

“…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”